title: Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D(3)).
authors.forename: I
authors.initials: I
authors.lastname: Molnár
authors.forename: N
authors.initials: N
authors.lastname: Stark
authors.forename: J
authors.initials: J
authors.lastname: Lovato
authors.forename: B L
authors.initials: BL
authors.lastname: Powell
authors.forename: J
authors.initials: J
authors.lastname: Cruz
authors.forename: D D
authors.initials: DD
authors.lastname: Hurd
authors.forename: J S
authors.initials: JS
authors.lastname: Mathieu
authors.forename: T C
authors.initials: TC
authors.lastname: Chen
authors.forename: M F
authors.initials: MF
authors.lastname: Holick
authors.forename: S
authors.initials: S
authors.lastname: Cambra
authors.forename: R P
authors.initials: RP
authors.lastname: McQuellon
authors.forename: G G
authors.initials: GG
authors.lastname: Schwartz
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D002762:Cholecalciferol / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000523:psychology; D011788:Quality of Life
chemical_list: D002762:Cholecalciferol